Quarterly ResultJul 9, 2026, 01:18 PM
Medinotec Q1 Revenue +24% to $2.65M; Net Income +95% to $222K
AI Summary
Medinotec Inc. reported strong financial results for the first quarter ended May 31, 2026, with revenue increasing by 24.23% to $2.65 million and net income surging by 95.12% to $222,014. Diluted EPS doubled to $0.02. However, income from operations decreased by 34.81% to $180,872, primarily due to a significant increase in selling expenses. The company continues to rely heavily on a single customer, DISA Life Sciences, which accounted for 87% of total revenue.
Key Highlights
- Revenue increased 24.23% to $2,651,095 for Q1 2026.
- Net income rose 95.12% to $222,014 for Q1 2026.
- Diluted EPS was $0.02 for Q1 2026, up from $0.01.
- Gross profit grew 43.21% to $1,307,665 for Q1 2026.
- Income from operations decreased 34.81% to $180,872.
- Net cash used in operations improved to $(176,125) from $(759,238) YoY.
- 87% of total revenue derived from a single customer, DISA Life Sciences.
- Total assets increased to $6,985,078 as of May 31, 2026.
Price Impact